Bibliografisk träff 2016-03-31 Novel tricyclics (e.g., GSK945237) as potent inhibitors of bacterial type IIA topoisomerases. Miles TJ, Hennessy AJ, Bax B, Brooks G, Brown BS, Brown P, Cailleau N, Chen D, Dabbs S, Davies DT, Esken JM, Giordano I, Hoover JL, Jones GE, Kusalakumari Sukmar SK, Markwell RE, Minthorn EA, Rittenhouse S, Gwynn MN, Pearson ND. Bioorg Med Chem Lett · journal article · DOI 10.1016/j.bmcl.2016.03.106